|
summary: This randomised double-blind placebo-controlled trial of a CCR1-antagonist drug was unfortunately not effective in preventing new MRI lesions in people with MS.
authors: Zipp F, Hartung HP, Hillert J, Schimrigk S, Trebst C, Stangel M, Infante-Duarte C, Jakobs P, Wolf C, Sandbrink R, Pohl C, Filippi M; CCR1 Antagonist Study Group.
source: Neurology. 2006 Nov 28;67(10):1880-3.
weblink: click here
category: Clinical Trials and Therapeutics
related research news: click here
glossary:
ACE
Chemokine
Lesion
Magnetic Resonance Imaging (MRI)
Multiple sclerosis
Placebo
Plaque
Randomised
Sclerosis
Sign
|
